Microcaps® Theophylline ER
Designed to reduce the high drug concentrations associated with traditional theophylline formulations, Eurand’s sustained-release formulations can decrease incidence of patient side effects.
| Therapeutic Category | Respiratory |
| Indication |
|
| Available Dosage Strength(s) |
|
| Product Description |
|
| Eurand Technology | |
| Data |
|
| Advantages |
|
This information is provided solely for the purpose of the evaluation of business opportunities by potential collaboration partners. The information is based on currently existing data and marketing authorizations in a number of jurisdictions and should not be assumed to be approved by regulatory authorities in any individual country. Consumers should consult with their individual physician for product information and should not rely upon any information provided here.
For more information on this product, please contact us at partners@eurand.com.
More Information
For more information, contact Eurand at partners@eurand.com or +1-267-759-9340
contact Eurand +